Factors influencing post-partum women’s choice of an implantable contraceptive device in a rural district hospital in South Africa by Potgieter, Francois et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=ojfp20
South African Family Practice
ISSN: 2078-6190 (Print) 2078-6204 (Online) Journal homepage: https://www.tandfonline.com/loi/ojfp20
Factors influencing post-partum women’s choice
of an implantable contraceptive device in a rural
district hospital in South Africa
Francois Potgieter, Paul Kapp & Francois Coetzee
To cite this article: Francois Potgieter, Paul Kapp & Francois Coetzee (2018) Factors influencing
post-partum women’s choice of an implantable contraceptive device in a rural district hospital in
South Africa, South African Family Practice, 60:6, 174-180, DOI: 10.1080/20786190.2018.1487213
To link to this article:  https://doi.org/10.1080/20786190.2018.1487213
© 2018 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group
Published online: 14 Aug 2018.
Submit your article to this journal 
Article views: 413
View Crossmark data
Factors inﬂuencing post-partum women’s choice of an implantable
contraceptive device in a rural district hospital in South Africa
Francois Potgietera, Paul Kappa and Francois Coetzeeb*
aDepartment of Family and Emergency Medicine, Stellenbosch University, Knysna, South Africa
bUkwanda Centre for Rural Health, Stellenbosch University, Worcester, South Africa
*Corresponding author, email: franna@sun.ac.za
Background: A single-rod subdermal contraceptive implant containing 68 mg of etonogestrel, ImplanonNXT®, was introduced
to the South African healthcare system in 2014. Initially the new device was well received but later uptake tapered off. A need
was identified to determine the factors that influence women’s choices with regard to the use of ImplanonNXT® in order to
improve its uptake. The aim of this study was to explore the factors that influence women’s choice of ImplanonNXT®.
Method: A qualitative study was performed, using semi-structured interviews to explore patients’ knowledge, attitudes and
beliefs regarding ImplanonNXT®. Ten patients were interviewed at Knysna Hospital.
Findings: There was confusion amongst women about the harms and benefits of using ImplanonNXT® and it became apparent
contraceptive counselling during pregnancy greatly affects the choices they make. Other factors that influenced the
participants’ choice with regard to contraception included social influences, preference for familiar methods and the side
effect profile of the various options.
Perceptions of the adverse side effects of the implantable device added to confusion and fear of this method, which influenced
women’s ideas about the use of ImplanonNXT®. Poor communication and reluctance from clinic staff to discuss ImplanonNXT®
during antenatal visits contributed to poor knowledge about the implantable device and its side effects.
Conclusion: Clearer communication during antenatal visits with pregnant women may address some of the fears and beliefs
that surround its side effects, workings and efficacy. The fear of possible side effects should be a focus for counselling and
education, as it predominantly contributes to women’s confusion and fear of the device. Further research is needed to
address this as well as evaluate if interventions such as better counselling and a dedicated team approach can change the
attitudes and beliefs of post-partum women towards the ImplanonNXT® device in the South African district health system.
Keywords: long acting reversible contraception, barriers, post partum, perceptions, choice
Introduction
TheSouthAfricaDemographic andHealth Survey report released in
2017 indicated that about 58.3% of women use some form of con-
traception1.During this time in theEdendistrictof theWesternCape
Province the majority of women reported using injectables (71%)
while 24% used oral contraceptives. Some 13% of women reported
making use of the intrauterine contraceptive device (IUCD) while
less than 1% used ImplanonNXT®, the other long-acting reversible
contraception (LARC) available in the Eden district.2
ImplanonNXT® was introduced to South Africa in 2014, adding
a second LARC option for women in addition to the IUCD.
ImplanonNXT® was launched in South Africa and not Implanon®.
Even though they are the same contraceptive, the Impla-
nonNXT® contains Barium and has a specially designed applica-
tor to avoid deep insertions. For the rest of the article
ImplanonNXT® will be referred to as Implanon®. The Department
of Health (DOH) invested a lot of time and finances into making
this new protective device available to all, since it was promoted
to increase the ‘couple year protection rate’, provide better
family spacing and decrease unwanted pregnancies.3
Healthcare workers also promoted this new LARC as a method of
contraception in the postpartum period, but since 2015 its
popularity in South Africa has decreased significantly.4
The decline in use of the implantable device in the areas sur-
rounding Knysna Hospital was also evident in the local
subdistrict maternal health statistics. It showed a 50.0% decrease
in ImplanonNXT® uptake from 48 to 24 units per month over a
16-month period.5
This initial acceptance by postpartum women and the sub-
sequent rapid decline begs the question as to what factors influ-
enced their decision.
LARCs like ImplanonNXT® havebeen in use since 1998. Implanon®
was first introduced in Indonesia, and subsequently approved for
use in over 60 countries by 2003.6 It showed a much better con-
tinuation rate and similar side-effect profile when comparedwith
other contraceptive devices.7–10 Previous studies from Thailand
and Ethiopia have shown that proximity to health care,
women’s age and education can play a role in their choice of con-
traception.11,12 Other factors that determine the choice of contra-
ception are partner preference and the cost of contraception.10,13
KnysnaHospital, situated in theGarden Route of theWestern Cape
in South Africa, serves a significant population and there are about
50 000 women seeking family planning services each year.14 As
only 170 IUCDs were inserted in the two subdistricts during
2013, the acceptance of this method seemed to be low.14 Local
hospital labourward statistics showed that the three-month inject-
able contraceptivewas themost commonmethodchosenbypost-
partum women.14 Previous investigators have found that women
tend to choose the contraceptive method advocated by their
healthcare providers.11,15 At present there is a need in South
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Africa to better understand the extent and reasons for a decline in
use of the implantable device.16 The aim of this study was to
explore the factors that influence women’s choice of Impla-
nonNXT® in the South African context.
Methods
Setting
The town of Knysna has a large divide between rich and poor
with the biggest portion of the population dependent on the
government health system. In 2011, 24.8% of the Knysna popu-
lation were unemployed and 73% lived in formal dwellings.17
The hospital acts as the drainage area for two subdistricts with
a combined population of 120 000 people. 17 These districts
are Knysna (60 000) and Bitou (Plettenberg Bay, 60 000). In
Knysna and Bitou the majority of the population are Africans
or mixed ethnicity people and dependent on the government
health system. The mixed ethnicity population are mainly Chris-
tian, while the majority of the Africans follow their own cultures.
The study was done at Knysna provincial hospital. The labour
ward is the only maternity unit in the subdistricts of Knysna
and Bitou. There is an average of five to six live births per day,
with a Caesarean section rate of between 20% and 30%. The
teenage pregnancy rate for 2016 was 14.0%.18
All women attending antenatal visits at their primary health
clinics are counselled during their pregnancy. Contraceptive
counselling forms part of these routine visits, which are mainly
managed by professional nursing staff. Contraceptive counsel-
ling is done again after delivery, and previously documented
decisions are checked before contraception is administered.
This task is the responsibility of the professional nursing staff of
the labourward and formspart of theirmanyduties post-delivery.
Sampling
The study population consisted of all postpartum women who
delivered at Knysna Provincial hospital labour ward between
February 2015 and August 2015. Purposive sampling was
used: women in the labour ward were asked if they were
willing to participate in the study. Willing women who did not
possess any of the exclusion criteria were interviewed. Women
were excluded if they were unable or did not consent, did not
speak English, Afrikaans or Xhosa, were younger than 18 years
of age (due to consent), or had any contraindications to the
implantable contraceptive device. Two women declined to par-
ticipate in the study claiming time and transport restrictions.
Data collection
Semi-structured individual interviews with 10 participants were
conducted by the researcher, making use of a discussion schedule
(see Appendix A) that provided guidance, but was not strictly
adhered to, to allow for new topics to be developed. Interviews
were conducted in English or Afrikaans and translated into English.
The following topics were explored:
. Patients’ knowledge and ideas regarding their current con-
traceptive method;
. Patients’ knowledge regarding the implantable contracep-
tive device;
. Patients’ personal and reproductive circumstances that
may influence choice;
. Patients’ perceptions of the implantable contraceptive
device;
. Any factors that may influence the choice of an implanta-
ble device.
The discussion schedule was based on knowledge of factors that
play a role in the choice of contraception in women in their
reproductive years.19,20 To ensure that the patients were comfor-
table, the interviews were held in a private room within the hos-
pital to minimise interruptions. All interviews were audio-
recorded and transcribed verbatim. A research diary was kept
by the researcher with field notes containing extra information
during interviews, which was added to the transcripts.
Data analysis
The transcribed data were analysed using the framework
method.21 The researcher immersed himself in the data, and a
thematic index was developed by coding the data and organis-
ing the codes into categories using the Atlas-ti (https://atlasti.-
com/) qualitative analysis software. The transcripts were
indexed by systematically applying the codes in the thematic
index to all the data. Charting was done to bring together all
data that had the same codes. These were then interpreted by
the researcher to identify the range and depth of different
themes and any relationships between themes. The field notes
assisted with developing the themes and further analysis of
the data. Validity was tested by respondent validation of the
conclusions. Results were confirmed with interviewees by
phone after the study data were analysed.
Trustworthiness
To ensure trustworthiness of the study three constructs were uti-
lised.22 The researcher ensured that sufficient contextual infor-
mation was provided on the participants and the research
setting to enable the reader to judge whether the results are
transferable to other settings and could be replicated in other
settings. For confirmability, a reflexive paragraph was added
by the researcher to explain the view taken by the researcher.
An independent transcriber was used, and the accuracy of the
transcriptions was checked against the original recordings.
Reflexive paragraph
The researcher is a Caucasian, Afrikaans-speaking South African
male in his thirties working as a Family Medicine registrar in the
Knysna and Bitou sub-districts and interested in improving the
couple-year contraceptive protection rate.
Ethical considerations
The study was approved by the Stellenbosch University Health
Research Ethics Committee (HREC approval no. S14/07/149)
and permission obtained from the Western Cape Department
of Health (WC_2015RP50_54). The research was conducted in
agreement with the Helsinki ethical code of conduct, the
South African Council for Good Ethical Practice and the
Medical Research Council Ethical Committee for Research.
Findings
Four themes were identified with regard to factors that influence
women’s choice of LARC in the postpartum period (see Figure 1).
Demographics
Participants were between the ages of 23 and 35 with six being
of the coloured race. Four were unemployed and three from a
middle-income group. All participants were in a relationship
with only three of them married. The majority were of the Chris-
tian religion.
Factors influencing post-partum women’s choice of an implantable contraceptive device in a rural district hospital in South Africa 175
Quotes were assigned tags to link them with the participants.
Each participant was assigned a number and R, E and M rep-
resent whether they are in a relationship, engaged or married.
For example ‘M4,25’ indicates participant number 4, and that
she is married and 25 years of age (see Table 1).
Theme 1: fear and confusion
Many of the participants are of the opinion that social and per-
sonal factors influence their choice of contraception. While their
partner’s opinion, family responsibility and financial factors
increased fear surrounding the device, the opinions of the
general public, family, friends and the media were also negative
towards Implanon®, contributing to the women’s fear of this new
device and increasing the confusion surrounding contraceptive
choice. As a result, many women became sceptical about the
LARC. They avoided its use, which decreased the device’s accep-
tance amongst participants.
Some married women suggested that input from husbands
could affect their contraceptive choice, while others thought
that it is their sole responsibility to ensure that they are pro-
tected against pregnancy:
‘It is you, you as a woman have a huge responsibility. You
can either have intercourse with a condom which is not
hundred per cent; you don’t have to tell your partner
you have the implant, because why I’m saying that is
because he is just going to tell you some stage to have
it removed.’ [R3,26]
For some participants, being employed seemed to have little to
no inﬂuence on their choice of contraception. Others feared
losing their employment because of absences from work
and that the implantable contraceptive device meant that
they do not have to go to the clinic and miss work at all for
three years:
‘I think the implant is better… . So you must go to the
clinic every time for the pill. And the implant is something
inside you, and it lasts long… . You’re at work every day if
you use it.’ [R9,23]
Some women were of the opinion word of mouth contributes to
negative perceptions, that once formed are tough to change.
Implanon® is no exception as fearful beliefs concerning the phys-
ical side effects spread amongst the female population:
‘What I can say is what I have heard, your body build
changes, you lose weight or your skin, something is
wrong with your skin. Almost like rash or something,
hair loss. It is almost like, as the side effects, it is almost
like stress.’ [R3,26]
Confusion was created as patients found the information from
the public contradicted what was discussed at the clinic. Some
felt that public opinion outweighs the promotion done by
healthcare workers:
‘I really do not know. Everything is confusing then I am not
sure whether to believe the doctors or the other people,
but after talking to other people I decided not to [take
the device].’ [R8,23]
Some interviewees claimed that they were inﬂuenced by what
they heard on the radio. This led to doubt about the device
and caused participants to fear the efﬁcacy of the device and
its side effects:
‘I’ve heard on the radio that some of the other women
who put the Implanon® on are wanting to take it off, I
don’t know the main reason why in the Eastern Cape
and they say it also causes, I don’t know what’s this
thing… . I forgot about it now, but they say it.’ [R7,19]
Theme 2: contraceptive counselling during pregnancy
Counselling about contraception choice post-delivery happens
during the first antenatal clinic visit. This decision is documented
and confirmed postpartum before contraception administration.
The healthcare workers’ counselling approach, information
sharing and product promotion were identified as factors
within our healthcare system that have an influence on
women’s beliefs about and perception of Implanon®.
Women mentioned that the way in which the topic was
approached discouraged them from discussing contraceptive
options. This approach led to them not taking part in this critical
decision-making moment and left them with little information
about the device:
Figure 1: Factors inﬂuencing women to choose or avoid Implanon®.
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‘I have sat in the clinic a couple of times where nurses, for
instance, would lecture everyone who sits there… . I think
that the thing for me was when I went to the clinic I got a
feeling even though I’m a married woman and I’ve got a
job, and I’m not you know, some you know random
person, that you are almost treated as if you have been
very irresponsible.’ [M1,35]
The timing of counselling seemed to be of concern as some
interviewees claimed that they did not need contraception
counselling once they were already pregnant and the focus
should fall more on non-pregnant women:
‘They did, they did say something about the implant, but
maybe it’s because I was not paying any attention to… .
I was already pregnant, yes, so I couldn’t find a reason to
listen to what they were saying at that time.’ [R7,19]
Participants felt that if they had more information about the
device, they would be less confused, less fearful and have less
doubt. For women to accept an implantable device for three
years, more information is needed for them to feel comfortable
with this new method of contraception. The lack of information
led to little knowledge about the device and left one participant
confused and with more questions than answers about its
functionality:
‘They say it is like a snake thing. I’m asking myself how is it
possible to go in the arm, is there a way how the body can,
why in the arm when things happen below. That is tricky.’
[R4,27]
Many women felt that not enough was being done at clinic level
to support the device and advocate its use. They felt that better
awareness of the instrument might convince women to accept it
as their ﬁrst-choice contraceptive:
‘Yeah, they ask you after birth, which contraception are
you going to use? Yeah, but they didn’t explain anything
about the implant and stuff.’ [M2,32]
Theme 3: preference for the familiar method
According to some respondents, a major factor influencing
women not to use the implantable contraceptive device was
being familiar with their previous method of contraception.
There were participants who were happy with their current con-
traceptive method and gave various reasons why they were
reluctant to change.
Women were not prepared to experiment if their current contra-
ception was working and they were not experiencing any
problems:
‘I’m happy, I stick with what I’m having; I never had any
problems.’ [E5,33]
Some women who experienced side effects from their current
contraceptive method nevertheless felt that they would rather
stick with it than change to a method that was new and
unfamiliar:
‘I guess it is the devil you know… because you know
there is a week in that cycle that I’m going to start
getting grumpy because it always happens. So that is,
you kind of know exactly what you are dealing with; I
mean as if I have the implant, I can’t just pull it out if it
is, you know, causing distress. And then you’ve got to
learn all over again, you know, how to handle that.’
[M1,35]
Theme 4: side effects and benefits experienced
Women mentioned many product-related factors that affected
their acceptance of the contraceptive device. Although the
side effects influenced some women not to use the device, for
others the advantages and ease of use made it their preferred
method of choice.
All women received counselling about the side-effect profile of
the implantable contraceptive device. Some women were not
prepared to take the risk of experiencing any of the well-
known side effects:
‘There are some of them who had removed it when they
got headaches and dizziness, and there are also people
who bleed nonstop. So that is why I have decided not
to use it.’ [R8,23]
Many women who chose Implanon® did so for its three-year pro-
tective cover compared with the shorter cover provided by com-
peting products. Other beneﬁts mentioned were the simple
procedure of acquiring the device and removal thereof:
‘It is actually, it is almost like a little “close matter” [refer-
ring to sterilisation] that they actually do for you, for
three years you are closed, after the third year you can
close up again or you can have it removed… it is only a
Table 1: Demographics of participants
Age Race Parity Delivery Education Income Relationship Religion Residence
35 W 2 C/S Tertiary Middle income Married Christian Knysna
32 B 2 C/S Matric Low income Married Atheist Knysna
26 C 2 NVD Gr11 Unemployed Relationship Christian Plettenberg Bay
27 C 1 C/S Diploma Low income Relationship Christian Plettenberg Bay
33 C 2 C/S Tertiary Middle income Engaged Christian Knysna
23 C 3 NVD Gr9 Unemployed Married six years Christian Sedgefield
19 B 1 C/S Matric Unemployed Relationship Christian Plettenberg Bay
23 C 1 C/S Gr9 Unemployed Relationship Atheist Plettenberg Bay
23 C 1 NVD Matric Low income Relationship Christian Sedgefield
28 W 1 NVD Matric Middle income Relationship Christian Knysna
C/S = Caesarean section; NVD = normal vaginal delivery.
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needle they took and, but you don’t feel anything, it is
almost like an injection.’ [R3,26]
When participants compared Implanon® with their previous
choices of contraception (many were on an injectable contra-
ception), the implantable device was the preferred method
due to the ease of use:
‘I don’t have a problem with the Depo, but since we have
to always have to go three months, three months, at least
three years you get peace of mind.’ [M2,32]
Discussion
While some women were favourably disposed towards the new
LARC method, the themes that we identified left women uncer-
tain or negative about using the new implantable device in the
postpartum period and led to a decline in acceptance.
This study suggests that confusion and community perceptions
also play a significant role in the modest use of the method. This
importance of public perceptions when it comes to making a
choice in method for contraception is not to be underestimated
and there is the risk of misconceptions becoming embedded in
communities.23 In 2016 Pillay et al. interviewed 152 women who
attended clinics in the city of Johannesburg and had had
implants inserted. They found that 60% of users had the Impla-
non® removed within 12 months and 90% of all the users who
had it removed indicated that it was due to side effects.23
The data from this study suggests that this an important aspect
to consider, since a number of woman who were negatively
inclined towards the implantable device were exposed to
women who experienced side effects and had the device
removed.
This study looked at the reasons why woman avoided using
Implanon® or chose to use it, and it became apparent that
side effects experienced by users and other community
members had a negative influence when patients considered
using Implanon®. A number of studies looked at reasons for
having the Implanon® removed and found it was mostly due
to side effects experienced, of which changes in vaginal bleed-
ing was the commonest when they investigated the reasons
for premature removal of the implantable device.23–26
Women who received better information about the implantable
device displayed a positive attitude towards it as a contraceptive
choice. Similar to previous studies, it was found that acceptance
is much better if health staff advocated the device.27,28 All preg-
nant patients in the Knysna district have access to clinics and
attend antenatal visits during their pregnancy. This is where con-
traception should be discussed and planned, and all questions
regarding the new implantable contraceptive device answered.
All mothers interviewed have attended antenatal visits and were
in contact with the health system to discuss their contraceptive
concerns and choice after delivery. Despite this we found that
knowledge concerning the available contraceptive methods
among the postpartum participants remained inadequate. Pre-
vious interventions in Zambia have shown better acceptance
of LARC by making use of trained, dedicated providers to
counsel and distribute contraception.29 This reinforces the
importance of an adequate proper contraceptive discussion
with our patients during antenatal clinic visits to empower
women to make informed decisions regarding their choice of
family planning. This is also strongly supported by the recent
work of Adeagbo et al.30
Some mothers with a good understanding of the implantable
method believed that it is a convenient choice of contraception.
This study found that the side effects experienced by Implanon®
users negatively influenced the decisions of possible future
users in the community. Similar results were found in an Ethio-
pian study where women reported having a negative attitude
towards long acting contraceptive methods (LACM) due to alle-
gations of side effects among the community.31
In this study women who were exposed to positive feedback dis-
played a favourable attitude towards the Implanon® and were
willing to accept the device. This finding is encouraging but con-
tradicts findings in the First World where only 20% of women
found that peers influenced their contraceptive choice.32
All interviewees were either married, engaged or in a relation-
ship. Although it was mentioned that marriage might entitle
the husband to be more involved in the decision-making
process, the contraceptive choice appeared to be mainly the
responsibility of the women. Some women were adamant that
their partner had little influence in their decision. This is in
direct contrast with the study done in Ethiopia where they
found a significant reduction in LACM use if the partner did
not agree with their choice of contraception and two-thirds of
the women obtained permission from their partners before
using LARC.31 The participants in our study had full autonomy
in their choice of contraception and did not have to ask per-
mission before choosing their method of contraception. At
most, the women admitted that it might be a discussion or
shared decision-making process. The reason for this contrast in
results might be due to cultural and religious differences
between South African communities and those in rural Ethiopia
and the fact that all study participants in the Ethiopian study
were married.
Pleaner et al. recently made several recommendations to
support South Africa’s implantable device programme and
many of them are supported by the findings of this study.4
The recommendations that are echoed by our findings include:
. Capacity building of healthcare providers with a focus on
the bettering of healthcare workers’ counselling skills and
making them more patient centred;
. Increasing demand for the implantable device by dispel-
ling myths, addressing fears and ensuring that the commu-
nity has accurate information about the device.
It is uncertain how well the side effects of Implanon® are
managed at clinic level.
There were several limitations to this study as it was conducted
at a single site which greatly limits the transferability of the data.
Interviews were performed by a single interviewer who was
easily identifiable as a physician working at the institution,
which may have brought about some bias in the gathering of
data. The interviews were conducted in the labour ward and
this may have increased the hierarchical power differential
between the interviewer and the interviewees. This may have
restricted women from discussing ideas freely. The study per-
formed by Pillay et al. suggests it would have been better to
gather data on the perceptions of patients coming to the
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clinics for contraceptive services, since many patients who chose
the Implanon® self-presented to primary facilities after hearing
about the device from family members and community
members.23
Conclusion
Although the public sector has made a significant investment
in the launching and implementation of the implantable
device in South Africa, this study and others have found that
the use of this LARC has met with many challenges and a
decline in popularity.4,23,25 This study identify key areas that
influence women’s decision-making and attitude towards the
Implanon® device and its acceptance as contraceptive
method of choice in the postpartum period, and highlights
the role of information sharing with our patients with regard
to contraceptive choices.
Further research is needed to investigate this and evaluate
whether interventions such as better counselling and a dedi-
cated team approach can change the attitudes and beliefs of
postpartum women and communities towards the Implanon®
device in the South African district health system.
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Appendix A
Discussion schedule
Introductions; discuss what the research is about and why par-
ticipant was chosen, address confidentiality and get a consent
form signed.
Confirm characteristics (age, parity, education, marital status
etc.) to ensure proper representation of the population.
‘As the new implantable contraceptive is new to everyone, the
medical staff and the patients, we are trying to understand
why woman choose to use or not to use it so that we can
improve the acceptance rate of it.’
Main question: ‘I’d like for you to tell me what contraception
you choose to use?’
*How does it make you feel? /What do you think about it?
Knowledge of contraception
What do you know about implantable contraception?
Is it an effective contraceptive method?
How long does it work for?
What do you know about other available contraceptive choices?
What do you know about the side effects of the implantable and
other contraceptive methods?
Personal and reproductive circumstances that can
inﬂuence decisions
How old were you when you were first pregnant?
Wanted/planned pregnancy?
How many children do you have?
Do you want more children?
What contraception does your husband prefer?
Does work have any influence on your choice of contraception?
HIV status?
Positive and negative perceptions of the implant
What bad stories have you heard about the implant?
What good stories have your heard about the implant?
What do you think?
Any factors that can lead to an increase in acceptance of
the implant
When the nurse/doctor tells you about contraception, what do
you want to know?
Can you think of anything that will influence other women to
choose the implant?
Did anyone talk to you about the use of the implant during your
pregnancy?
What do you think should be the man’s responsibility towards
contraception?
How were you counselled about contraception during your
pregnancy?
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